Angelini Pharma is the pharmaceutical division of the Angelini Group.
Angelini Pharma is a healthcare and wellbeing leader, with unique strength and expertise in the fields of mental health (included pain) and rare diseases. It aims to help patients, physicians and caregivers in the fight against diseases. The company is also a leading player in the Consumer Health segment, with highly successful OTC brands in Italy and abroad.
The company operates directly in 15 countries employing about 2,700 people and its products are marketed in more than 70 countries through strategic alliances with leading international pharmaceutical groups.
As part of its internationalisation strategy, Angelini Pharma has also concentrated development in countries with high growth potential.
Angelini Pharma in figures
- 2,700 Employees
- 3 Production sites in Italy
- 50% Turnover from abroad
- 70 Countries in which products are marketed
Angelini Pharma is an integrated pharmaceutical company, with an extensive R&D operation that has developed important molecules such as trazodone and benzydamine.
Current research focuses on pain and inflammation, diseases and disorders of the nervous system with a particular commitment to the research of new treatments for the paediatric population.
The research embraces public-private partnerships with recognised academic institutions and centres of global importance. The Scientific Network and Partnerships both have an important role in creating innovation.
Angelini's Italy based “world class” production plants use cutting-edge technologies and have full certification for quality standards and respect for the environment. Extensive use is made of renewable energy sources and sustainability in general.
In Italy, the Ancona plant produces finished pharmaceutical products and the industrial factory in Aprilia creates raw pharmaceutical materials, while disinfectants and sanitising products under the Amuchina brand are produced in Casella.
Visit our website